Following peripheral inflammation, NMDA receptor (NMDAR) activation in spinal cord dorsal horn neurons facilitates the generation of pain in response to low threshold inputs (allodynia) and signals the phosphorylation of protein kinase C (pPKC) and extracellular signal-regulated kinase 2 (pERK2). Intraplantar complete Freund's adjuvant (CFA) induces inflammatory nociception (allodynic pain) at 24 hours (h) with a concurrent increase in neuronal pPKCc and pERK2 but not glial pERK2. These effects are attenuated in a spatial knockout of the NMDAR (NR1 KO) confined to SCDH neurons. Although glia and proinflammatory cytokines are implicated in the maintenance of inflammatory pain and neuronal activation, the role of NMDARs and neuronal-glial-cytokine interactions that initiate and maintain inflammatory pain are not well defined. In the maintenance phase of inflammatory pain at 96 h after CFA the NR1 KO mice are no longer protected from allodynia and the SCDH expression of pPKCc and pERK2 are increased. At 96 h the expression of the proinflammatory cytokine, IL-1b, and pERK2 are increased in astrocytes. Intrathecal IL-1 receptor antagonist (IL-1ra), acting on neuronal IL-1 receptors, completely reverses the allodynia at 96 h after CFA. Deletion of NMDAR-dependent signaling in neurons protects against early CFA-induced allodynia. Subsequent NMDAR-independent signaling that involves neuronal expression of pPKCc and the induction of pERK2 and IL-1b in activated astrocytes contributes to the emergence of NMDAR-independent inflammatory pain behavior at 96 h after CFA. Effective reduction of the initiation and maintenance of inflammatory pain requires targeting the neuron-astrocyte-cytokine interactions revealed in these studies. Ó
Introduction
Peripheral inflammatory mediators sensitize and activate high threshold primary sensory neurons and this activity is conducted to central terminals that synapse on second order neurons in the spinal cord dorsal horn (SCDH). With the intense and sustained noxious stimuli that are associated with persistent inflammation, there is a temporal summation of postsynaptic depolarizations, which removes the voltage-dependent magnesium block of N-methyl-Daspartate receptors (NMDAR) allowing calcium influx into the postsynaptic cell. This in turn activates calcium sensitive intracellular signal cascades that lead to rapid posttranscriptional changes such as the phosphorylation of the NR1 subunit of the NMDAR, the Kv4.2 potassium channel, [10] , protein kinase C (pPKC) and extracellular signal-regulated kinases, ERK1 and ERK2 (pERK1/2) [13] [14] [15] . These and other phosphorylated kinases can initiate events that lead to a later, sustained transcription of genes associated with pain such as COX-2, TrkB and BDNF [14] . The resulting prolonged increase in the excitability of spinal cord neurons and the recruitment of normally subliminal inputs leads to the spread of pain sensitivity beyond the site of inflammation (secondary hyperalgesia) and the generation of pain in response to low threshold inputs (allodynia). This process is described as central sensitization [33, 34] .
It is now well recognized that spinal glia (both microglia and astrocytes) are key contributors to persistent pain. Glia are activated by the neuronal excitation that occurs with inflammation, and in turn release proinflammatory cytokines that modulate neuronal excitability. The reciprocal interactions between neurons and glia amplify neuronal input, facilitating the maintenance of injuryinduced pain [24] . However, the neuron-glia signaling mechanisms involved in the initiation and maintenance of inflammatory pain are just beginning to emerge.
In previous studies, we have selectively targeted the functionally essential NR1 subunit of the NMDAR in the SCDH in vivo using the serotype-2 AAV vector. This vector selectively transduces 
